These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11386394

  • 1. Developing a disease-specific quality of life measure for people with multiple sclerosis.
    Ford HL, Gerry E, Tennant A, Whalley D, Haigh R, Johnson MH.
    Clin Rehabil; 2001 Jun; 15(3):247-58. PubMed ID: 11386394
    [Abstract] [Full Text] [Related]

  • 2. The validity and test-retest reliability of the Leeds Multiple Sclerosis Quality of Life scale in Turkish patients.
    Akbiyik DI, Sumbuloglu V, Guney Z, Armutlu K, Korkmaz N, Keser I, Yuksel MM, Karabudak R.
    Int J Rehabil Res; 2009 Jun; 32(2):162-6. PubMed ID: 19369887
    [Abstract] [Full Text] [Related]

  • 3. Structural and construct validity of the Leeds Multiple Sclerosis Quality of Life scale.
    Ensari I, Motl RW, McAuley E.
    Qual Life Res; 2016 Jun; 25(6):1605-11. PubMed ID: 26660145
    [Abstract] [Full Text] [Related]

  • 4. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ.
    Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
    [Abstract] [Full Text] [Related]

  • 5. Validation of the Stroke Specific Quality of Life Scale (SS-QOL): test of reliability and validity of the Danish version (SS-QOL-DK).
    Muus I, Williams LS, Ringsberg KC.
    Clin Rehabil; 2007 Jul; 21(7):620-7. PubMed ID: 17702704
    [Abstract] [Full Text] [Related]

  • 6. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS).
    Gold SM, Heesen C, Schulz H, Guder U, Mönch A, Gbadamosi J, Buhmann C, Schulz KH.
    Mult Scler; 2001 Apr; 7(2):119-30. PubMed ID: 11424632
    [Abstract] [Full Text] [Related]

  • 7. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
    Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A.
    Brain; 2001 May; 124(Pt 5):962-73. PubMed ID: 11335698
    [Abstract] [Full Text] [Related]

  • 8. Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale.
    Rigby SA, Domenech C, Thornton EW, Tedman S, Young CA.
    Mult Scler; 2003 Feb; 9(1):73-81. PubMed ID: 12617272
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ, Tepper SJ, Baos V, Baudet F, D'Amico D, Kilminster S.
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [Abstract] [Full Text] [Related]

  • 11. Measuring quality of life in multiple sclerosis: not as simple as it sounds.
    Nicholl L, Hobart JC, Cramp AF, Lowe-Strong AS.
    Mult Scler; 2005 Dec; 11(6):708-12. PubMed ID: 16320732
    [Abstract] [Full Text] [Related]

  • 12. Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS).
    Benito-León J, Martínez-Martín P, Frades B, Martínez-Ginés ML, de Andrés C, Meca-Lallana JE, Antigüedad AR, Huete-Antón B, Rodríguez-García E, Ruiz-Martínez J.
    Mult Scler; 2007 Jun; 13(5):645-51. PubMed ID: 17548445
    [Abstract] [Full Text] [Related]

  • 13. Evaluation and cultural adaptation of a German version of the AIMS2-SF questionnaire (German AIMS2-SF).
    Rosemann T, Körner T, Wensing M, Schneider A, Szecsenyi J.
    Rheumatology (Oxford); 2005 Sep; 44(9):1190-5. PubMed ID: 15972355
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods.
    Hobart J, Cano S.
    Health Technol Assess; 2009 Feb; 13(12):iii, ix-x, 1-177. PubMed ID: 19216837
    [Abstract] [Full Text] [Related]

  • 16. A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
    Goodwin E, Green C.
    Value Health; 2015 Dec; 18(8):1016-24. PubMed ID: 26686786
    [Abstract] [Full Text] [Related]

  • 17. A health-related quality of life measure for multiple sclerosis.
    Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW.
    Qual Life Res; 1995 Jun; 4(3):187-206. PubMed ID: 7613530
    [Abstract] [Full Text] [Related]

  • 18. Developing a measure of medication-related quality of life for people with polypharmacy.
    Tseng HM, Lee CH, Chen YJ, Hsu HH, Huang LY, Huang JL.
    Qual Life Res; 2016 May; 25(5):1295-302. PubMed ID: 26584811
    [Abstract] [Full Text] [Related]

  • 19. Methodological studies of orofacial aesthetics, orofacial function and oral health-related quality of life.
    Larsson P.
    Swed Dent J Suppl; 2010 May; (204):11-98. PubMed ID: 20623943
    [Abstract] [Full Text] [Related]

  • 20. Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale.
    Airlie J, Baker GA, Smith SJ, Young CA.
    Clin Rehabil; 2001 Jun; 15(3):259-65. PubMed ID: 11386395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.